66
Participants
Start Date
December 30, 2009
Primary Completion Date
January 12, 2017
Study Completion Date
January 12, 2017
Romiplostim
Administered by subcutaneous injection once a week.
Research Site, Randwick
Research Site, Parkville
Research Site, South Brisbane
Research Site, New York
Research Site, New York
Research Site, Pittsburgh
Research Site, Washington D.C.
Research Site, Atlanta
Research Site, Nashville
Research Site, Louisville
Research Site, Columbus
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, Detroit
Research Site, Iowa City
Research Site, Chicago
Research Site, Peoria
Research Site, Kansas City
Research Site, Omaha
Research Site, New Orleans
Research Site, Dallas
Research Site, Fort Worth
Research Site, Houston
Research Site, Las Vegas
Research Site, San Diego
Research Site, Orange
Research Site, New Brunswick
Research Site, Toronto
Research Site, Montreal
Research Site, Montreal
Research Site, Barcelona
Lead Sponsor
Amgen
INDUSTRY